HUMAN HERPESVIRUS 6
Abstract
Background. Human herpesvirus 6 belongs to betaherpesviruses. This is a lymphotropic virus which is widely spread in a population. The most frequent way of virus transmission is by saliva. For this reason the first contact usally occurs early in a childhood period. Clinical manifestation might be expressed as exanthem subitum or roseola infantum. In adults primary infections are a rare event while virus reactivation might be very frequent.
Conclusions. Human herpesvirus 6 is believed to be the most neurotropic among all herpesviruses. It even can cause central nervous system disease in an immunocompetent person. The most important role of human herpesvirus 6 is in provoking complications in HIV-infected individuals and in patients after organ transplantations, as it causes immunosupression even more severe. The possible connection of human herpesvirus 6 with multiple sclerosis, chronic fatigue syndrome and some neoplasmas remains to be clarified. Human herpesvirus 6 infection can be most easily diagnosed by serological methods; the virus could be detected by monoclonal antibodies and by the use of the methods of molecular biology.
Downloads
References
Josephs SF, Salahuddin SZ, Ablashi DV, Schachter F, Wong-Staal F, Gallo RC. Genomic analysis of the human B-lymphotropic virus (HBLV). Science 1986; 234: 601–3.
Frenkel N, Schirmer EC, Wyatt LS et al. Isolation of a new herpesvirus from CD4 T cells. Proc Natl Acad Sci USA 1990; 87: 748–52.
Chang Y, Cesarman E, Pessin MS et al. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi’s sarcoma. Science 1994; 266: 1865–9.
Martin J. Epidemiology of HHV-8 infection in Western countries. Fourth International Conference on Human Herpesviruses 6, 7 and 8. Book of Abstracts. Paris, 2001: 12–2.
Lindquester GJ, Inone N, Allen RD et al. Restriction endonuclease mapping and molecular cloning of human herpesvirus 6 variant B strain Z 29 genome. Arch Virol 1996; 141: 367–9.
Yamamoto M, Black JB, Stewart JA, Lopez C, Pellett P. Identification of a nucleocapsid protein as a specific serological marker of human herpesvirus 6 infection. J Clin Microbiol 1990; 28: 1957–62.
Gempels VA, Nicholas J, Lawrence G, Jones M, Thomson BJ, Martin ME. The DNA sequence of human herpesvirus-6: structure, coding content, and genome evolution. Virology 1995; 209: 29–51.
Cone RW, Huang ML, Ashkley R, Corey L. Human herpesvirus-6 DNA in periferal blood cells and saliva from immunocompetent individuals. J Clin Microbiol 1993; 31: 1262–7.
Cuende JI, Ruiz J, Civeira MP, Prieto J. High prevalence of HHV-6 DNA in peripheral blood mononuclear cells of healthy individuals detected by nested-PCR. J Med Virol 1994; 43: 115–8.
Hall CB, Long CE, Schnabel KC et al. Human herpesvirus-6 infection in children. A prospective study of complications and reactivation. N Engl J Med 1994; 331: 432–8.
Luppi M, Barozzi P, Maiorana A, Marasca R, Torelli G. Human herpesvirus6 infection in normal brain tissue. J Infect Dis 1994; 168: 943–4.
Luppi M, Barozzi P, Maiorana A et al. Human herpesvirus-6: a survey of presence and distribution of genome sequences in normal brain and neuroglial tumors. J Med Virol 1995; 47: 105–11.
Challoner PB, Smith KT, Parker JD et al. Plaque-associated expression of human herpesvirus 6 in multiple sclerosis. Proc Natl Acad Sci USA 1995; 92: 7440–4.
Hoshino K, Nishi T, Adachi H et al. Human herpesvirus-6 infection in renal allografts: retrospective immunohistochemical study in Japanese recipients. Transplant Int 1995; 8: 169–73.
Cone RW, Hackman RC, Huang ML et al. Human herpesvirus-6 in lung tissue from patients with pneumonitis after bone marrow transplantation. N Engl J Med 1993; 329: 156–61.
Okuno T, Oishi H, Hayashi K, Nonogyki M, Tanaka K, Yamanishi K. Human herpesvirus-6 and 7 in cervixes of pregnant women. J Clin Microbiol 1995; 33: 1968–70.
Leach CT, Newton ER, McParlin S, Jenson HB. Human herpesvirus-6 infection of the female genital tract. J Infect Dis 1994; 169: 1281–3.
Pruksananonda P, Hall CB, Insel RA et al. Primary human herpesvirus 6 infection in young children. N Engl J Med 1992; 326: 1445–50.
Yamanishi KT, Okuno K, Shiraki M et al. Identification of human herpesvirus 6 as a causal agent for exanthem subitum. Lancet 1988; 1: 1065–7.
Kondo K, Nagafuji H, Hata A, Tomomori C, Yamanishi K. Association of HHV-6 infection of the central nervous system with recurrence of febrile convulsions. J Infect Dis 1993; 167: 1197–200.
Harnett GB, Farr TJ, Pietroboni GR, Bucens MR. Frequent shedding of human herpesvirus 6 in saliva. J Med Virol 1990; 30: 128–30.
Aubin JT, Poirel L, Agut H et al. Intrauterine transmission of human herpesvirus 6. Lancet 1992; 340: 482–3.
Mendel I, DeMatteis M, Bertin C et al. Fulminant hepatitis in neonates with human herpesvirus 6 infection. Pediatr Infect Dis J 1995; 14: 993–7.
Marin J, Klemenc P, Beovič B. Humani herpesvirus 6 – navzočnost specifičnih protiteles IgG pri asimptomatskih posameznikih in pri izbranih skupinah bolnikov. 1. slovenski imunološki kongres z mednarodno udeležbo, Portorož. Med Razgl 2000; 39: 162–2.
DiLuca D, Mirandola P, Ravaioli T et al. Human herpesvirus 6 and 7 in salivary glands and shedding in saliva of healthy and human immunodeficiency virus positive individuals. J Med Virol 1995; 45: 462–8.
Di Luca D, Mirandola P, Secchiero P et al. Characterisation of human herpesvirus 6 strains isolated from patients with exanthem subitum with or without cutaneous rash. J Infect Dis 1992; 166: 689–9.
Burnstine RC, Paine RS. Residual encephalopathy following roseola infantum. AMA J Dis Child 1959; 98: 144–52.
Moller KL. Exanthema subitum and febrile convulsions. Acta Paediatr 1956; 45: 534–40.
Ishiguro N, Yamada, Takahashi T et al. Meningo-encephalitis associated with HHV-6 related exanthem subitum. Acta Paediatr Scand 1990; 79: 987– 9.
Whitley RJ. Viral encephalitis. N Engl J Med 1990; 323: 242–50.
Beovič B, Pečarič-Meglič N, Marin J, Bedernjak J, Muzlovič I, Čižman M. Fatal human herpesvirus 6-associated multifocal meningoencephalitis in an adult female patient. Scand J Infect Dis 2001; 33: 942–4.
Patnaik M, Pater JB. Intrathecal synthesis of antibodies to human herpesvirus-6 early antigen in patients with meningoencephalitis. Clin Infect Dis 1995; 21: 715–6.
Sola P, Merelli E, Marasca R et al. Human herpesvirus 6 and multiple sclerosis: survey of anti-HHV-6 antibodies by immunofluorescence analysis and of viral sequences by polymerase chain reaction. J Neurol Neurosurg Psychiat 1993; 56: 917–9.
Selmaj KW, Raine CS. Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro. Ann Neurol 1988; 23: 339–46.
Okuno T, Higashi K, Shiraki K et al. Human herpesvirus 6 infection in renal transplantation. Transpl 1990; 49: 519–22.
Merlino C, Giacchino F, Segoloni G, Ponzi AN. Human herpesvirus 6 infection and renal transplantation. Transpl 1992; 53: 1382–3.
Yalcin S, Karpuzoglu T, Suleymanlar G et al. Human herpesvirus 6 and 7 infections in renal transplant recipients and healthy adults in Turkey. Arch Virol 1994; 136: 183–90.
Yoshijawa T, Suga S, Asano Y et al. Human herpesvirus-6 infection in bone marrow transplantation. Blood 1992; 78: 1381–4.
Carrigan DR, Drobyski WR, Russler SK, Appler MA, Knox KK, Ash RC. Interstitial pneumonitis associated with human herpesvirus-6 infection after marrow transplantation. Lancet 1991; 338: 147–9.
Drobsky WR, Knox KK, Majewski D, Carrigen DR. Fatal encephalitis due to variant B human herpesvirus-6 infection in a bone marrow-transplant recipient. N Engl J Med 1994; 330: 1356–60.
Wilborn F, Brinkmann V, Schmidt CA, Neipel F, Gelderblom H, Seigert W. Herpesvirus type 6 in patients undergoing bone marrow transplantation: serologic features and detection by polymerase chain reaction. Blood 1994; 83: 3052–8.
Brown NA, Kovacs A, Lui CR, Hur C, Zaia A, Moley JW. Prevalence of antibody to human herpesvirus 6 among blood donors infected with HIV. Lancet 1988; 2: 1146–6.
Essers S, Schwinn J, Meulen J et al. Seroepidemiological correlations of antibodies to human herpesvirus and human immunodeficiency virus type 1 in African patients. Eur J Epidemiol 1991; 7: 658–64.
Fox J, Briggs M, Tedder RS. Antibody to human herpesvirus 6 in HIV-1 positive and negative homosexual men. Lancet 1988; 2: 396–7.
Ablashi DV, Josephs SF, Buchbinder C et al. Human B-lymphotropic virus (human herpesvirus-6). J Virol Methods 1988; 21: 29–48.
Spira TJ, Bozeman LH, Sanderlin KC et al. Lack of correlation between human herpesvirus-6 infection and the course of human immunodeficiency virus infection. J Infect Dis 1990; 161: 567–70.
Chen H, Pesce AM, Carbonari M et al. Absence of antibodies to human herpesvirus-6 in patients with slowly-progressive human immunodeficiency virus type 1 infection. Eur J Epidemiol 1992; 8: 217–21.
Gautheret A, Aubin JT, Fauveau V, Rozenbaum W, Huraux JM, Agut H. Rate of detection of human herpesvirus-6 at different stages of HIV infection. Eur J Microbiol Infect Dis 1995; 14: 420–4.
Gopal MR, Thomson BJ, Fox J, Tedder RS, Honess RW. Detection by PCR of HHV-6 and EBV DNA in blood and oropharynx of healthy adults and HIVseropositives. Lancet 1990; 335: 1598–9.
Fillet AM, Raphael M, Visse B, Audouin J, Poirel L, Agut H. Controlled study of human herpesvirus 6 detection in acquired immunodeficiency syndrome-associated non-Hodgkin’s lymphoma. J Med Virol 1995; 45: 106–12.
Knox KK, Carrigan DR. Active HHV-6 infection in the lymph nodes of HIV infected patients: in vitro evidence that HHV-6 can break HIV latency. J Acquired Immune Defic Syndr 1996: 11; 370–8.
Razzaque A. Oncogenic potencial of human herpesvirus-6 DNA. Oncogene 1990; 5: 1365–70.
Chen M, Popescu N, Woodworth C et al. Human herpesvirus 6 infects cervical epithelial cells and transactivates human papillomavirus gene expression. J Virol 1994; 68: 1173–8.
Jarrett RF, Gledhill S, Quereshi F et al. Identification of human herpesvirus6 specific DNA sequences in two patients with non-Hodgkin’s lymphoma. Leukemia 1988; 2: 296–502.
Josephs SF, Buchbinder A, Streicher HZ et al. Detection of human Blymphotropic virus (human herpesvirus 6) sequence in B cell lymphoma tissue of three patients. Leukemia 1988; 2: 132–5.
Luka J, Pirruccello SJ, Kersey JH. HHV-6 genome in T-cell acute lymphoblastic leukemia. Lancet 1991; 338: 1277–8.
Levine PH, Ebbesen P, Ablashi DV, Saxinger WC, Nordentoft A, Connelly RR. Antibodies to human herpesvirus-6 and clinical course in patients with Hodgkin’s disease. Int J Cancer 1992; 51: 53–7.
Luppi M, Barozzi P, Maiorana A et al. Frequency and distribution of herpesvirus-like DNA sequences (KSHV) in different stages of classic Kaposi’s sarcoma and in normal tissue from an Italian population. Int J Cancer 1996; 66: 437–41.
Yadav M, Chandrashekran A, Vasudevan DM, Ablashi DV. Frequent detection of human herpesvirus 6 in oral carcinoma. J Natl Cancer Inst 1994; 86: 1792–4.
zur Hausen H. Human papillomaviruses in the pathogenesis of anogenital cancer. Virology 1991; 184: 9–13.
Sairenyi T, Yamanishi K, Tachibana Y, Bertoni G, Kurata T. Antibody responses to Epstein-Barr virus, human herpesvirus 6 and human herpesvirus 7 in patients with chronic fatigue syndrome. Intervirology 1995; 38: 269–73.
Reeves WC, Pellett PE, Gary H. The chronic fatigue syndrome controversy. Ann Intern Med 1992; 117: 343–3.
Ranger-Rogez S, Vidal E, Labrousse F et al. Large-scale study suggests no direct link between human herpesvirus-6 and primary Sjogren’s syndrome. J Med Virol 1995; 47: 198–203.
Asano Y, Nakashima T, Yoshikawa T, Suga S, Yazaki T. Severity of human herpesvirus-6 viremia and clinical findings in infants with exanthem subitum. J Pediatr 1991; 118: 891–5.
Balachandran N, Amelse RE, Zhou WW, Chang K. Identification of proteins specific for herpesvirus 6-infected human T cells. J Virol 1989; 63: 2835–40.
Campadelli-Fiume G, Guerrini S, Liu X, Foa-Tomasi L. Monoclonal antibodies to glycoprotein B differentiate human herpesvirus 6 into two clusters, variants A and B. J Gen Virol 1993; 98: 2257–62.
Yamamoto T, Mukai T, Kondo K, Yamanishi K. Variation of DNA sequence in immediate-early gene of human herpesvirus 6 and variant identification by PCR. J Clin Microbiol 1994; 32: 473–6.
Chou S, Marousek GI. Analysis of interstrain variation in a putative immediate-early region of human herpesvirus 6 DNA and definition of variantspecific sequences. Virology 1994; 198: 370–6.
Huang LM, Kuo PF, Lee CY, Chen JY, Liu MY, Yang CS. Detection of human herpesvirus-6 DNA by polymerase chain reaction in serum or plasma. J Med Virol 1992; 38: 7–10.
Black JB, Schwartz TF, Patton JL et al. Evaluation of immunoassays for detection of antibodies to human herpesvirus 7. Clin Diagn Lab Immunol 1996; 3: 79–83.
Ward KN, Gray JJ, Joslin ME, Sheldon MJ. Avidity of IgG antibodies to human herpesvirus-6 distingishes primary from recurrent infection in organ transplant recipients and excludes cross-reactivity with other herpesviruses. J Med Virol 1993; 39: 44–9.
Williams MV. HHV-6 response to antiviral agents. In: Ablashi DV, Krueger GRF, Salahuddin SZ eds. Human herpesvirus-6: epidemiology, molecular biology, and clinical pathology. Amsterdam: Elsevier Biomedical Press, 1992: 317–35.
The Author transfers to the Publisher (Zdravniški vestnik/Slovenian Medical Journal) all economic copyrights following form Article 22 of the Slovene Copyright and Related Rights Act (ZASP), including the right of reproduction, the right of distribution, the rental right, the right of public performance, the right of public transmission, the right of public communication by means of phonograms and videograms, the right of public presentation, the right of broadcasting, the right of rebroadcasting, the right of secondary broadcasting, the right of communication to the public, the right of transformation, the right of audiovisual adaptation and all other rights of the author according to ZASP.
The aforementioned rights are transferred non-exclusively, for an unlimited number of editions, for the term of the statutory
The Author can make use of his work himself or transfer subjective rights to others only after 3 months from date of first publishing in the journal Zdravniški vestnik/Slovenian Medical Journal.
The Publisher (Zdravniški vestnik/Slovenian Medical Journal) has the right to transfer the rights, acquired parties without explicit consent of the Author.
The Author consents that the Article be published under the Creative Commons BY-NC 4.0 (attribution-non-commercial) or comparable licence.
